Patients who are unable to swallow whole tablets are not eligible
Patients who are unable to swallow intact tablets are not eligible
Patients who are unable to swallow whole tablets are not eligible
Inability to swallow intact tablets
Inability to swallow intact tablets
Participant is unable to swallow or absorb oral tablets.
Patients who are unable to swallow tablets or liquid are not eligible.
The participant is unable to swallow tablets that are whole (do not crush or chew or administer via nasogastric [NG]-tube)
Unable or unwilling to swallow tablets as per dosing schedule
Subjects that cannot swallow tablets.
Subject is unable to swallow or absorb oral tablets normally
Unable or unwilling to swallow tablets or capsules
Patients who are unable to swallow erlotinib tablets are not eligible
Patients who are unable to swallow tablets or have a gastrointestinal disease that could hinder the absorption of enzalutamide.
Unable to swallow tablets.
Inability to swallow intact tablets
Unable or unwilling to swallow tablets or capsules
Inability to swallow intact tablets
Inability to swallow intact tablets
Unable or unwilling to swallow tablets
The subject is unable to swallow tablets
Unable or unwilling to swallow tablets
The subject is unable to swallow tablets
Subject is unable to swallow or absorb oral tablets normally
Unable to swallow tablets
Patients who cannot swallow whole tablets (i.e. medication tablets)
Unwilling or unable to swallow tablets BID
The subject is unable to swallow tablets
The subject is unable to swallow tablets
Allergy to valacyclovir or unable to take oral tablets
The subject is unable to swallow tablets
The subject is unable to swallow capsules or tablets
Unable or unwilling to swallow tablets BID
Unable or unwilling to swallow tablets
Unable to swallow tablets
The subject is unable to swallow tablets
Any condition causing an inability to swallow tablets.
The subject is unable to swallow tablets
Inability to swallow tablets
The subject is unable to swallow tablets
Inability to swallow tablets
Inability to swallow tablets or use of a feeding tube
Patients who are unable or unwilling to swallow tablets
Participant is unable or unwilling to swallow tablets
The subject is unable to swallow tablets
The subject is unable to swallow capsules tablets
The participant is unable to swallow capsules or tablets
Patients who are unable to swallow tablets
The subject is unable to swallow tablets
The subject is unable to swallow tablets
Subject is unable to swallow capsules or tablets
Unable or unwilling to swallow BBI608, BBI503, or sorafenib capsules or tablets
The subject is unable to swallow tablets
The subject is unable to swallow tablets
Inability to swallow tablets for everolimus arm
Inability to swallow tablets
Inability to swallow tablets
